Adding oral amisulpride to prevent nausea after gynecologic surgery
Part of Digestive system clinical trials.
This trial tests if adding a medication called amisulpride to standard anti-nausea drugs can better prevent vomiting and nausea after gynecologic surgery. It is for women at high risk of postoperative nausea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having laparoscopic hysterectomy surgery for a non-cancerous condition (like fibroids or endometriosis without cancer).
- You have a high risk of nausea and vomiting after surgery, as determined by a score of 3 or 4 on the Apfel scale.
- You are in good general health (ASA class 1 or 2).
- You cannot be pregnant or breastfeeding, and you must not have certain heart rhythm problems, low potassium, or Parkinson’s disease.
- You are not currently taking antipsychotic medications and have not taken anti-nausea medications or steroids within 24 hours before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an aprepitant injection to prevent nausea and vomiting after laparoscopic gynecologic or abdominal surgery lasting at least 1 hour. It may be an option for people who want to reduce post-operative sickness.
This trial tests whether a medication called amisulpride can reduce nausea and vomiting after gynecological surgery (surgery on the ovaries, fallopian tubes, or uterus using small incisions). Many patients feel sick after surgery, and this study aims to find out if this drug helps prevent that.
This trial tests a combination of methods to prevent nausea and vomiting after gynecological surgery using a laparoscope (a small camera). The study uses acupressure and other supportive care techniques to see if they can reduce post-surgery nausea, which is a common and uncomfortable side effect.
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
This study tests two different medication combinations to prevent nausea and vomiting after laparoscopic gallbladder removal surgery. You'll receive either ondansetron plus metoclopramide, or dexamethasone plus metoclopramide, and researchers will track how quickly you need rescue medication if nausea occurs.
Hear when a new Post Operative Nausea and Vomiting (PONV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.